Literature DB >> 6823012

Adenovirus-induced alterations of the cell growth cycle: a requirement for expression of E1A but not of E1B.

A W Braithwaite, B F Cheetham, P Li, C R Parish, L K Waldron-Stevens, A J Bellett.   

Abstract

Mutants dl312, dl314, hr1, and hr3 with mutations in region E1A of adenovirus type 5 were defective for the induction of cell cycle abnormalities detectable by flow cytometry, cell DNA replication, thymidine kinase production, and chromosome aberrations and did not synthesize the viral DNA-binding protein (E2A) in rat cells. dl311, a leaky E1A mutant, induced cell cycle effects at high multiplicity in only one of three experiments, and synthesized the DNA-binding protein. hr7 (E1B) gave a wild-type response in all tests. dl313 was also positive in all tests, although it induced fewer polyploid cells than did wild-type virus, probably because of the leftward extension of the dl313 E1B deletion into E1A. sub315 and sub316, with mutations which also span the E1A-E1B border, synthesized DNA-binding protein, but caused no cell cycle alterations detectable by flow cytometry in rat or mouse cells. Although the participation of other viral early regions cannot be completely excluded, our results suggest that alteration of cell cycle progression is a direct effect of E1A unrelated to its control of other viral early regions, and may be the function of E1A in transformation.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6823012      PMCID: PMC256401     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

1.  Adenovirus assay by the fluorescent cell-counting procedure.

Authors:  L PHILIPSON
Journal:  Virology       Date:  1961-11       Impact factor: 3.616

Review 2.  Viruses and chromosomes.

Authors:  H F Sitch; D S Yohn
Journal:  Prog Med Virol       Date:  1970

3.  The response of BHK21 cells to infection with type 12 adenovirus. II. Relationship of virus-stimulated DNA synthesis to other viral functions.

Authors:  W A Strohl
Journal:  Virology       Date:  1969-12       Impact factor: 3.616

4.  Induction of DNA synthesis by adenoviruses in contact-inhibited hamster cells.

Authors:  H Shimojo; T Yamashita
Journal:  Virology       Date:  1968-11       Impact factor: 3.616

5.  A rapid single step staining technique for DNA analysis by flow microfluorimetry.

Authors:  I W Taylor
Journal:  J Histochem Cytochem       Date:  1980-09       Impact factor: 2.479

6.  Adenovirus antigens--a study of their properties and sequential development in infection.

Authors:  W C Russell; K Hayashi; P J Sanderson; H G Pereira
Journal:  J Gen Virol       Date:  1967-10       Impact factor: 3.891

7.  Altered cell cycle progression and aberrant mitosis in adenovirus-infected rodent cells.

Authors:  J D Murray; A J Bellett; A w Braithwaite; L K Waldron; I W Taylor
Journal:  J Cell Physiol       Date:  1982-04       Impact factor: 6.384

8.  Transformation-deficient adenovirus mutant defective in expression of region 1A but not region 1B.

Authors:  D Solnick; M A Anderson
Journal:  J Virol       Date:  1982-04       Impact factor: 5.103

9.  Partial transformation of primary rat cells by the leftmost 4.5% fragment of adenovirus 5 DNA.

Authors:  A Houweling; P J van den Elsen; A J van der Eb
Journal:  Virology       Date:  1980-09       Impact factor: 3.616

10.  Dependence of tumor-forming capacities of cells transformed by recombinants between adenovirus types 5 and 12 on expression of early region 1.

Authors:  K Shiroki; K Maruyama; I Saito; Y Fukui; K Yazaki; H Shimojo
Journal:  J Virol       Date:  1982-05       Impact factor: 5.103

View more
  45 in total

Review 1.  Does the antitumor adenovirus ONYX-015/dl1520 selectively target cells defective in the p53 pathway?

Authors:  B R Dix; S J Edwards; A W Braithwaite
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

2.  Relationship between organization of the actin cytoskeleton and the cell cycle in normal and adenovirus-infected rat cells.

Authors:  P Jackson; A J Bellett
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

3.  Adenovirus E1A is associated with a serine/threonine protein kinase.

Authors:  C H Herrmann; L K Su; E Harlow
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

4.  Induction of c-fos mRNA and AP-1 DNA-binding activity by cAMP in cooperation with either the adenovirus 243- or the adenovirus 289-amino acid E1A protein.

Authors:  D A Engel; U Muller; R W Gedrich; J S Eubanks; T Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

5.  Adenovirus type 2 activates cell cycle-dependent genes that are a subset of those activated by serum.

Authors:  H T Liu; R Baserga; W E Mercer
Journal:  Mol Cell Biol       Date:  1985-11       Impact factor: 4.272

6.  Induction of cell cycle progression by adenovirus E1A gene 13S- and 12S-mRNA products in quiescent rat cells.

Authors:  T Nakajima; M Masuda-Murata; E Hara; K Oda
Journal:  Mol Cell Biol       Date:  1987-10       Impact factor: 4.272

7.  Individual adenovirus type 5 early region 1A gene products elicit distinct alterations of cellular morphology and gene expression.

Authors:  B E Roberts; J S Miller; D Kimelman; C L Cepko; I R Lemischka; R C Mulligan
Journal:  J Virol       Date:  1985-11       Impact factor: 5.103

8.  The role of mouse adenovirus type 1 early region 1A in acute and persistent infections in mice.

Authors:  K Smith; C C Brown; K R Spindler
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

9.  Adenovirus E1A activates cyclin A gene transcription in the absence of growth factors through interaction with p107.

Authors:  K Zerfass; D Spitkovsky; A Schulze; S Joswig; B Henglein; P Jansen-Dürr
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

10.  The replicative capacities of large E1B-null group A and group C adenoviruses are independent of host cell p53 status.

Authors:  A S Turnell; R J Grand; P H Gallimore
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.